Griffith University’s Institute for Glycomics and Melbourne-based company Paradigm Biopharmaceuticals Limited (ASX: PAR) have reported impressive results from their Phase 2A clinical trials of a new drug candidate to treat viral arthritis (joint pain/stiffness) caused by mosquito-borne alphavirus infections, including the debilitating Ross River virus (RRV) and chikungunya virus (CHIKV).
From hot dogs and potato chips to chicken nuggets and sugary sodas, Americans are eating more ultra-processed foods (UPFs) than ever. Researchers estimate that up…
A trial at English secondary schools of alternative food labeling—which displayed the number of minutes of physical activity needed to burn off calories—reduced the purchase…
A new review has found evidence that music-based therapy may benefit people living with dementia, particularly by improving symptoms of depression. The work has been…
Researchers from Houston Methodist Hospital, UCLA, the University of Toronto, and others have tried to answer a longstanding fear that undergoing surgery on a Friday…
University of California, Los Angeles researchers have discovered that chronic stress flips brain activity between two amygdala-striatal pathways, disrupting flexible decision-making and promoting inflexible …
A radioactive gas could be contributing to asthma among schoolkids, researchers have found.
Current asthma treatments don’t work in all patients, and they don’t provide long-term relief from potentially deadly asthma attacks.
New research has found that supplementing the maternal diet with α-tocopherol, a form of vitamin E, can reduce the development of food allergy and anaphylaxis…
In a surprising discovery, scientists have found that the heart possesses “sweet taste” receptors, similar to those on our tongues, and that stimulating these receptors…
A simple scoring system could revolutionize how doctors prevent heart attacks and strokes by identifying patients most likely to benefit from preventive medications, according to…
